BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 17555831)

  • 41. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation.
    Lowdell MW; Shamim F; Hamon M; Macdonald ID; Prentice HG
    Exp Hematol; 1995 Dec; 23(14):1530-4. PubMed ID: 8542943
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Molecular mechanisms whereby immunomodulatory drugs activate natural killer cells: clinical application.
    Hayashi T; Hideshima T; Akiyama M; Podar K; Yasui H; Raje N; Kumar S; Chauhan D; Treon SP; Richardson P; Anderson KC
    Br J Haematol; 2005 Jan; 128(2):192-203. PubMed ID: 15638853
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Bortezomib and depsipeptide sensitize tumors to tumor necrosis factor-related apoptosis-inducing ligand: a novel method to potentiate natural killer cell tumor cytotoxicity.
    Lundqvist A; Abrams SI; Schrump DS; Alvarez G; Suffredini D; Berg M; Childs R
    Cancer Res; 2006 Jul; 66(14):7317-25. PubMed ID: 16849582
    [TBL] [Abstract][Full Text] [Related]  

  • 44. IL-2/CD40-driven NK cells install and maintain potency in the anti-mesothelioma effector/memory phase.
    Jackaman C; Lansley S; Allan JE; Robinson BW; Nelson DJ
    Int Immunol; 2012 Jun; 24(6):357-68. PubMed ID: 22354912
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Human tumor-derived exosomes selectively impair lymphocyte responses to interleukin-2.
    Clayton A; Mitchell JP; Court J; Mason MD; Tabi Z
    Cancer Res; 2007 Aug; 67(15):7458-66. PubMed ID: 17671216
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tumor-derived lactate modifies antitumor immune response: effect on myeloid-derived suppressor cells and NK cells.
    Husain Z; Huang Y; Seth P; Sukhatme VP
    J Immunol; 2013 Aug; 191(3):1486-95. PubMed ID: 23817426
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Exosomes for the Enhanced Tissue Bioavailability and Efficacy of Curcumin.
    Aqil F; Munagala R; Jeyabalan J; Agrawal AK; Gupta R
    AAPS J; 2017 Nov; 19(6):1691-1702. PubMed ID: 29047044
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Impaired natural killer cell lysis in breast cancer patients with high levels of psychological stress is associated with altered expression of killer immunoglobin-like receptors.
    Varker KA; Terrell CE; Welt M; Suleiman S; Thornton L; Andersen BL; Carson WE
    J Surg Res; 2007 May; 139(1):36-44. PubMed ID: 17292412
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The human ortholog of granulocyte macrophage colony-stimulating factor and interleukin-2 fusion protein induces potent ex vivo natural killer cell activation and maturation.
    Penafuerte C; Bautista-Lopez N; Boulassel MR; Routy JP; Galipeau J
    Cancer Res; 2009 Dec; 69(23):9020-8. PubMed ID: 19920194
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [The roles of soluble MICA in immune escape of breast tumor].
    Ye YB; Zhou ZF; Chen Q; Li JY; Chen X; Huang WW
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Sep; 24(9):904-7. PubMed ID: 18782524
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Immunoselection of breast and ovarian cancer cells with trastuzumab and natural killer cells: selective escape of CD44high/CD24low/HER2low breast cancer stem cells.
    Reim F; Dombrowski Y; Ritter C; Buttmann M; Häusler S; Ossadnik M; Krockenberger M; Beier D; Beier CP; Dietl J; Becker JC; Hönig A; Wischhusen J
    Cancer Res; 2009 Oct; 69(20):8058-66. PubMed ID: 19826050
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Negative regulation of tumor-infiltrating NK cell in clear cell renal cell carcinoma patients through the exosomal pathway.
    Xia Y; Zhang Q; Zhen Q; Zhao Y; Liu N; Li T; Hao Y; Zhang Y; Luo C; Wu X
    Oncotarget; 2017 Jun; 8(23):37783-37795. PubMed ID: 28384121
    [TBL] [Abstract][Full Text] [Related]  

  • 53. NK cell adoptive transfer combined with Ontak-mediated regulatory T cell elimination induces effective adaptive antitumor immune responses.
    Salagianni M; Lekka E; Moustaki A; Iliopoulou EG; Baxevanis CN; Papamichail M; Perez SA
    J Immunol; 2011 Mar; 186(6):3327-35. PubMed ID: 21317394
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Interleukin 18 induces the sequential activation of natural killer cells and cytotoxic T lymphocytes to protect syngeneic mice from transplantation with Meth A sarcoma.
    Micallef MJ; Tanimoto T; Kohno K; Ikeda M; Kurimoto M
    Cancer Res; 1997 Oct; 57(20):4557-63. PubMed ID: 9377569
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Novel delivery of sorafenib by natural killer cell-derived exosomes-enhanced apoptosis in triple-negative breast cancer.
    Hashemi ZS; Ghavami M; Kiaie SH; Mohammadi F; Barough MS; Khalili S; Hosseini-Farjam Z; Mossahebi-Mohammadi M; Sheidary A; Ghavamzadeh A; Forooshani RS
    Nanomedicine (Lond); 2023 Feb; 18(5):437-453. PubMed ID: 37199259
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Bifacial effects of engineering tumour cell-derived exosomes on human natural killer cells.
    Li Q; Huang Q; Huyan T; Wang Y; Huang Q; Shi J
    Exp Cell Res; 2018 Feb; 363(2):141-150. PubMed ID: 29269076
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Decreased NK-cell tumour immunosurveillance consequent to JAK inhibition enhances metastasis in breast cancer models.
    Bottos A; Gotthardt D; Gill JW; Gattelli A; Frei A; Tzankov A; Sexl V; Wodnar-Filipowicz A; Hynes NE
    Nat Commun; 2016 Jul; 7():12258. PubMed ID: 27406745
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Biodistribution and Immune Suppressive Effects of Breast Cancer-Derived Exosomes.
    Wen SW; Sceneay J; Lima LG; Wong CS; Becker M; Krumeich S; Lobb RJ; Castillo V; Wong KN; Ellis S; Parker BS; Möller A
    Cancer Res; 2016 Dec; 76(23):6816-6827. PubMed ID: 27760789
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Characterization of Human NK Cell-Derived Exosomes: Role of DNAM1 Receptor In Exosome-Mediated Cytotoxicity Against Tumor.
    Di Pace AL; Tumino N; Besi F; Alicata C; Conti LA; Munari E; Maggi E; Vacca P; Moretta L
    Cancers (Basel); 2020 Mar; 12(3):. PubMed ID: 32178479
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Human breast cancer and impaired NK cell function.
    Garner WL; Minton JP; James AG; Hoffmann CC
    J Surg Oncol; 1983 Sep; 24(1):64-6. PubMed ID: 6887939
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.